Impact of Brexit on the Pharma & Medical Device Industries
Benefits of attending
- Hear the latest information on Brexit and how it will affect the life science sector
- Discuss the outstanding issues and what actions need to be taken to prepare for Brexit
- Gain an insight into the MHRA perspective on Brexit
- Discuss the specific issues relevant to both the Medical Technology and Pharma Industries
- Explore the impact on both existing and new products
Why should you attend?
With Britain’s exit from the European Union fast approaching, the new arrangements for all aspects of the regulation of Pharmaceuticals, Medical Devices and IVDs between the UK and EU 27 pose major challenges.
The ramifications of Brexit after more than 40 years of ever deepening integration and alignment across the Life Science sector will be immense, whatever the final form Brexit takes.
This meeting will enable you to hear the latest information from our expert speaker panel to help you understand the changes that are required and ensure you are ready as the deadlines approach.